PharmaShots | Incisive News in 3 Shots

Subscribe Now

AiCuris

AiCuris Entered into a WW License Agreement with Hybridize to Develop & Commercialize RNA-Based Therapy Against BK Virus

AiCuris Entered into a WW License Agreement with Hybridize to Develop & Commercialize RNA-Based Therapy Against BK Virus

February 10, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us